Metropolitan Life Insurance CO Supernus Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

41 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$27.11 - $35.17 $7,075 - $9,179	-261 Reduced 9.08%	2,615 $89,000
Q3 2023 Nov 14, 2023	BUY	$27.57 - $32.91 $6,092 - $7,273	221 Added 8.32%	2,876 $79,000
Q2 2023 Aug 10, 2023	SELL	$29.91 - $38.73 $4,875 - $6,312	-163 Reduced 5.78%	2,655 $79,000
Q1 2023 May 15, 2023	SELL	$34.93 - $42.03 $8,697 - $10,465	-249 Reduced 8.12%	2,818 $102,000
Q4 2022 Jun 14, 2023	BUY	$31.09 - $37.88 $7,741 - $9,432	249 Added 8.84%	3,067 $109 Million
Q4 2022 Mar 30, 2023	BUY	$31.09 - $37.88 $4,632 - $5,644	149 Added 5.11%	3,067 $109,000
Q4 2022 Feb 15, 2023	BUY	$31.09 - $37.88 $4,632 - $5,644	149 Added 5.11%	3,067 $109,000
Q3 2022 Jun 14, 2023	BUY	$28.79 - $35.41 $2,879 - $3,540	100 Added 3.55%	2,918 $98.8 Million
Q2 2022 Jun 20, 2023	BUY	$25.33 - $34.25 $2,533 - $3,425	100 Added 3.55%	2,918 $84,000
Q1 2022 Jun 20, 2023	BUY	$28.51 - $32.9 $2,851 - $3,290	100 Added 3.55%	2,918 $94,000
Q1 2022 Mar 30, 2023	SELL	$28.51 - $32.9 $294,821 - $340,218	-10,341 Reduced 77.99%	2,918 $94,000
Q1 2022 May 12, 2022	SELL	$28.51 - $32.9 $294,821 - $340,218	-10,341 Reduced 77.99%	2,918 $94,000
Q4 2021 Jun 21, 2023	BUY	$26.37 - $34.22 $275,329 - $357,291	10,441 Added 370.51%	13,259 $386,000
Q3 2021 Jun 21, 2023	BUY	$23.54 - $31.39 $245,781 - $327,742	10,441 Added 370.51%	13,259 $353,000
Q3 2021 Mar 30, 2023	SELL	$23.54 - $31.39 $60,097 - $80,138	-2,553 Reduced 16.15%	13,259 $353,000
Q3 2021 Nov 15, 2021	SELL	$23.54 - $31.39 $60,097 - $80,138	-2,553 Reduced 16.15%	13,259 $354,000
Q2 2021 Jun 21, 2023	BUY	$26.72 - $33.19 $347,199 - $431,270	12,994 Added 461.11%	15,812 $486,000
Q2 2021 Mar 30, 2023	BUY	$26.72 - $33.19 $15,631 - $19,416	585 Added 3.84%	15,812 $486,000
Q2 2021 Aug 16, 2021	BUY	$26.72 - $33.19 $422,095 - $524,302	15,797 Added 105313.33%	15,812 $487,000
Q1 2021 Jun 26, 2023	BUY	$24.15 - $31.45 $299,677 - $390,263	12,409 Added 440.35%	15,227 $399 Million
Q1 2021 Mar 30, 2023	SELL	$24.15 - $31.45 $16,349 - $21,291	-677 Reduced 4.26%	15,227 $398,000
Q1 2021 May 14, 2021	SELL	$24.15 - $31.45 $383,719 - $499,709	-15,889 Reduced 99.91%	15 $399,000
Q4 2020 Jun 22, 2023	BUY	$17.7 - $25.81 $231,622 - $337,749	13,086 Added 464.37%	15,904 $400,000
Q3 2020 Jun 26, 2023	BUY	$20.2 - $25.05 $264,337 - $327,804	13,086 Added 464.37%	15,904 $331,000
Q2 2020 Jun 26, 2023	BUY	$17.09 - $24.89 $223,639 - $325,710	13,086 Added 464.37%	15,904 $377,000
Q1 2020 Jul 12, 2023	BUY	$14.45 - $24.69 $189,092 - $323,093	13,086 Added 464.37%	15,904 $286,000
Q4 2019 Jul 12, 2023	BUY	$19.93 - $29.13 $260,803 - $381,195	13,086 Added 464.37%	15,904 $377,000
Q3 2019 Jul 12, 2023	BUY	$25.47 - $33.37 $333,300 - $436,679	13,086 Added 464.37%	15,904 $437,000
Q2 2019 Jul 12, 2023	BUY	$29.96 - $38.87 $392,056 - $508,652	13,086 Added 464.37%	15,904 $526,000
Q1 2019 Jul 13, 2023	BUY	$32.77 - $41.99 $428,828 - $549,481	13,086 Added 464.37%	15,904 $557,000
Q1 2019 Mar 30, 2023	BUY	$32.77 - $41.99 $420,668 - $539,025	12,837 Added 418.55%	15,904 $557,000
Q1 2019 May 16, 2019	BUY	$32.77 - $41.99 $238,729 - $305,897	7,285 Added 84.52%	15,904 $557,000
Q1 2019 May 15, 2019	SELL	$32.77 - $41.99 $238,729 - $305,897	-7,285 Reduced 45.81%	8,619 $1.02 Million
Q4 2018 Jul 13, 2023	BUY	$30.84 - $49.51 $403,572 - $647,887	13,086 Added 464.37%	15,904 $528,000
Q4 2018 Feb 14, 2019	BUY	$30.84 - $49.51 $383,187 - $615,161	12,425 Added 357.14%	15,904 $528,000
Q3 2018 Jul 13, 2023	BUY	$42.7 - $56.55 $558,772 - $740,013	13,086 Added 464.37%	15,904 $801 Million
Q3 2018 Nov 14, 2018	SELL	$42.7 - $56.55 $530,547 - $702,633	-12,425 Reduced 78.13%	3,479 $175,000
Q2 2018 Aug 15, 2018	BUY	$44.1 - $59.85 $8,246 - $11,191	187 Added 1.19%	15,904 $0
Q4 2017 Feb 15, 2018	SELL	$36.4 - $42.6 $567,148 - $663,750	-15,581 Reduced 49.78%	15,717 $626,000
Q3 2017 Nov 14, 2017	SELL	$36.75 - $49.65 $87,759 - $118,564	-2,388 Reduced 7.09%	31,298 $1.25 Million
Q2 2017 Aug 14, 2017	BUY	N/A	33,686	33,686 $1.45 Million

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

Black Rock Inc. New York, NY

10.4M
Shares

$376 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

6.13M
Shares

$221 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.1M
Shares

$184 Million
2.64% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.88M
Shares

$104 Million
0.02% of portfolio
Macquarie Group LTD Australia, C3

2.63M
Shares

$95.1 Million
0.09% of portfolio

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account